Skip to main content

Table 1 Summary of patient characteristics

From: Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis

Characteristic Atomoxetine Methylphenidate Total
Age mean (SD)    
Gender n(%)    
Male 1030 (79.8) 973(75.4) 2003(77.6)
Female 260(20.2) 317(25.6) 577 (22.4)
Ethnic origin    
Caucasian 871 (61.8) 946 (72.7) 1817(67.0)
Others 539 (38.2) 355 (27.3) 894(33.0)
ADHD subtype    
Hyperactive/impulsive 19 (2.3) 11 (2.0) 30 (2.2)
Inattentive 191 (23.3) 152 (28.3) 343(25.3)
combined 609 (74.4) 374 (69.7) 983 (72.5)
Prior stimulant use- yes 544 (55.0) 528 (41.4) 1072 (47.4)
Comorbid oppositional defiant disorder 273 (39.0) 134 (31.1) 407(36.0)